Selective pulmonary artery perfusion followed by blood flow occlusion: New challenge for the treatment of pulmonary malignancies

Lung Cancer

Volumn 63, Issue 3, 2009, Pages 400-404

  Grootenboers, Marco J J H ^a   Schramel, Franz M N H ^a   van Boven, Wim J ^a   Hendriks, Jeroen M H ^b   van Schil, Paul E Y ^b   De Wit, Peter E J ^c   Pasterkamp, Gerard ^d   Folkerts, Gert ^e   van Putte, Bart P ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c AMPHIA HOSPITAL   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Blood flow occlusion; Gemcitabine; Pharmacokinetics; Pulmonary malignancies; Selective pulmonary artery perfusion

Indexed keywords

GEMCITABINE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTERY CATHETERIZATION; ARTICLE; BALLOON CATHETER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG EXPOSURE; DRUG LIVER LEVEL; DRUG TISSUE LEVEL; FEMALE; FOLLOW UP; LUNG BLOOD FLOW; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; SELECTIVE LUNG ARTERY PERFUSION; STUDENT T TEST; SWINE; THORACOTOMY; TISSUE SECTION;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BALLOON DILATATION; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBOLIZATION, THERAPEUTIC; FEMALE; INFUSIONS, INTRA-ARTERIAL; LUNG NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PERFUSION; PULMONARY ARTERY; RIBONUCLEOTIDE REDUCTASES; SWINE; TREATMENT OUTCOME;

EID: 59249105106     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.06.009     Document Type: Article

References (13)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics. CA Cancer J Clin 56 (2006) 106-130
2. Hendriks J.M., Grootenboers M.J., Schramel F.M., van Boven W.J., Stockman B., Seldenrijk C.A., et al. Isolated lung perfusion with melphalan for patients with resectable pulmonary metastases: a phase I trial. Ann Thorac Surg 78 (2004) 1919-1927
3. Grootenboers M.J., Hendriks J.M., van Boven W.J., Knibbe C.A., van Putte B., Stockman B., et al. Pharmacokinetics of isolated lung perfusion with melphalan for resectable pulmonary metastases, a phase I and extension trial. J Surg Oncol 96 (2007) 583-589
4. Van Putte B.P., Grootenboers M., van Boven W.J., Hendriks J.M., van Schil P.E., Guetens G., et al. Pharmacokinetics of gemcitabine when delivered by selective pulmonary artery perfusion for the treatment of lung cancer. Drug Metab Dispos 36 (2008) 676-681
5. Van Putte B.P., Hendriks J.M., Romijn S., Pauwels B., De Boeck G., Guetens G., et al. Pharmacokinetics after pulmonary artery perfusion with gemcitabine. Ann Thorac Surg 76 (2003) 1036-1040
6. Karakousis C.P., Park H.C., Sharma S.D., and Kanter P. Regional chemotherapy via the pulmonary artery for pulmonary metastases. J Surg Oncol 18 (1981) 249-255
7. Wang H.Y., Ng B., Blumberg D., Port J.L., Hochwald S.N., and Burt M.E. Pulmonary artery perfusion of doxorubicin with blood flow occlusion: pharmacokinetics and treatment in a metastatic sarcoma model. Ann Thorac Surg 60 (1995) 1390-1394
8. Furrer M., Lardinois D., Thormann W., Altermatt H.J., Betticher D., Triller J., et al. Cytostatic lung perfusion by use of an endovascular blood flow occlusion technique. Ann Thorac Surg 65 (1998) 1523-1528
9. Krueger T., Kuemmerle A., Kosinski M., Denys A., Magnusson L., Stupp R., et al. Cytostatic lung perfusion results in heterogeneous spatial regional blood flow and drug distribution: evaluation of different cytostatic lung perfusion techniques in a porcine model. J Thorac Cardiovasc Surg 132 (2006) 304-311
10. Brown D.B., Cai S.R., Fundakowski C.E., Zamboni W.C., Strychor S., and McLeod H.L. Pharmacokinetics after endovascular lung perfusion with cisplatin. J Vasc Interv Radiol 17 (2006) 883-888
11. Van Putte B.P., Hendriks J.M., Romijn S., Pauwels B., Friedel G., Guetens G., et al. Isolated lung perfusion with gemcitabine in a rat: pharmacokinetics and survival. J Surg Res 109 (2003) 118-122
12. Mueller H. Combined regional and systemic chemotherapy for advanced and inoperable non-small cell lung cancer. Eur J Surg Oncol 28 (2002) 165-171
13. Guadagni S., Mueller H., Valenti M., Clementi M., Fiorentini G., Cantore M., et al. Thoracic stop-flow perfusion in the treatment of refractory non small cell lung cancer. J Chemother 16 (2004) 40-43